Literature DB >> 6616079

Post-operative serum sialyltransferase levels and prognosis in breast cancer.

J Stewart, R Rubens, R Millis, J Hayward, S Hoare, R Bulbrook, D Kessel.   

Abstract

Serum sialyltransferase (SST) activity was measured 10 days after mastectomy in 153 patients with operable breast cancer. Enzyme activity declined with time in storage (1-42 months). After correction for loss of activity in storage, patients with SST activity below the median value had a longer disease-free interval (DFI) than those with SST activity above the median, and this difference remained when patients were stratified by axillary nodal status, tumor size, and tumor grade. Survival was longer in patients with low SST activity. Post-operative elevation of SST indicates a poor prognosis in patients with operable breast cancer.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6616079     DOI: 10.1007/bf01803565

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  18 in total

1.  Alterations in plasma sialyltransferase levels in patients with neoplastic disease.

Authors:  M Henderson; D Kessel
Journal:  Cancer       Date:  1977-03       Impact factor: 6.860

2.  Increase in serum and tissue glycosyltransferases and glycosidases in tumor-bearing rats.

Authors:  C Ip; T L Dao
Journal:  Cancer Res       Date:  1977-09       Impact factor: 12.701

3.  Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast.

Authors:  J W Meakin; W E Allt; F A Beale; R S Bush; R M Clark; P J Fitzpatrick; N V Hawkins; R D Jenkin; J F Pringle; J G Reid; W D Rider; J L Hayward; R D Bulbrook
Journal:  Eur J Cancer       Date:  1980       Impact factor: 9.162

4.  Serum sialyltransferase and 5'-nucleotidase as reliable biomarkers in women with breast cancer.

Authors:  T L Dao; C Ip; J Patel
Journal:  J Natl Cancer Inst       Date:  1980-09       Impact factor: 13.506

5.  Concomitant elevations in serum sialytransferase activity and sialic acid content in rats with metastasizing mammary tumors.

Authors:  R J Bernacki; U Kim
Journal:  Science       Date:  1977-02-11       Impact factor: 47.728

6.  Serum sialyltransferase levels as a parameter in the diagnosis and follow-up of gastrointestinal tumors.

Authors:  U Ganzinger; E Deutsch
Journal:  Cancer Res       Date:  1980-04       Impact factor: 12.701

7.  Characterization of sialytransferase in noncancerous and neoplastic human liver tissue.

Authors:  H A Ingraham; J A Alhadeff
Journal:  J Natl Cancer Inst       Date:  1978-12       Impact factor: 13.506

8.  Correlation of serum, tumor, and liver serum glycoprotein: N-acetylneuraminic acid transferase activity with growth of the R3230AC mammary tumor in rats and relationship of the serum activity to tumor burden.

Authors:  I M Evans; R Hilf; M Murphy; H B Bosmann
Journal:  Cancer Res       Date:  1980-09       Impact factor: 12.701

9.  Enzyme activity in invasive tumors of human breast and colon.

Authors:  H B Bosmann; T C Hall
Journal:  Proc Natl Acad Sci U S A       Date:  1974-05       Impact factor: 11.205

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.